Inflammaging constitutes the common factor for comorbidities predisposing to severe COVID-19. Inflammaging leads to T-cell senescence, and immunosenescence is linked to autoimmune manifestations in COVID-19. As in SLE, metabolic dysregulation occurs in T-cells. Targeting this T-cell dysfunction opens the field for new therapeutic strategies to prevent severe COVID-19. Immunometabolism-mediated approaches such as rapamycin, metformin and dimethyl fumarate, may optimize COVID-19 treatment of the elderly and patients at risk for severe disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803547 | PMC |
| http://dx.doi.org/10.18632/aging.202422 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The impact of COVID-19 on accelerating of immunosenescence and brain aging.
Front Cell Neurosci
December 2024
Max Planck Institute for Human Development Center for Lifespan Psychology, Berlin, Germany.
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global health, affecting not only the immediate morbidity and mortality rates but also long-term health outcomes across various populations. Although the acute effects of COVID-19 on the respiratory system have initially been the primary focus, it is increasingly evident that the virus can have significant impacts on multiple physiological systems, including the nervous and immune systems. The pandemic has highlighted the complex interplay between viral infection, immune aging, and brain health, that can potentially accelerate neuroimmune aging and contribute to the persistence of long COVID conditions.
View Article and Find Full Text PDFLong-Term Physical Activity Mitigates Inflammaging Progression in Older Adults Amidst the COVID-19 Pandemic.
Int J Environ Res Public Health
October 2024
Postgraduate Program in Health Science, Santo Amaro University (UNISA), São Paulo 04829-300, Brazil.
Background: Inflammaging and physical performance were investigated in older adults before and after the COVID-19 pandemic.
Methods: Older women ( = 18) and men ( = 7) (mean age = 73.8 ± 7.
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.
AIDS
November 2024
Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Article Synopsis
- A study assessed how long COVID-19 antibodies last in 93 people with HIV after receiving an mRNA booster vaccination.
- Researchers explored the impact of T-cell dysfunction and certain aging-related biomarkers on the duration of these antibody responses.
- They discovered that specific immune cell ratios and characteristics (like a low CD4/CD8 ratio) are linked to quicker declines in antibody levels, enhancing our understanding of immune responses in HIV patients after vaccination.
Rapid progression of CD8 and CD4 T cells to cellular exhaustion and senescence during SARS-CoV2 infection.
J Leukoc Biol
November 2024
Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais (UFMG), Av. Antonio Carlos, 6627, 31270-901, Belo Horizonte, MG, Brazil.
Risk factors for the development of severe COVID-19 include several comorbidities, but age was the most striking one since elderly people were disproportionately affected by SARS-CoV-2 infection. Among the reasons for this markedly unfavorable response in the elderly, immunosenescence and inflammaging appear as major drivers of this outcome. A finding that was also notable was that hospitalized patients with severe COVID-19 have an accumulation of senescent T cells, suggesting that immunosenescence may be aggravated by SARS-CoV-2 infection.
View Article and Find Full Text PDFPredictivity of the Prognostic Nutritional Index and Systemic Inflammation Index for All-Cause In-Hospital Mortality in Geriatric and Adult COVID-19 Inpatients.
J Clin Med
July 2024
Division of Geriatrics, Department of Internal Medicine, Ege University Hospital, 35100 İzmir, Türkiye.
The prognostic nutritional index (PNI) and the systemic immune inflammation index (SII) have been used as simple risk-stratification predictors for COVID-19 severity and mortality in the general population. However, the associations between these indices and mortality might differ due to age-related changes such as inflammaging and several comorbid conditions in older patients. Therefore, we aimed to compare the predictivity of the PNI and SII for mortality among hospitalized older patients and patients under 65 years old.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!